Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

El Salvador Adopts Bitcoin as Currency

El Salvador on Tuesday became the first country to adopt Bitcoin as…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pelosi’s Archbishop: ‘You Cannot Be a Good Catholic and Support…Right to Kill Innocent Human Beings’

Catholic Archbishop Salvatore Cordileone of San Francisco,…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Lindsey Graham Predicts The U.S. Military ‘Will Be Going Back Into Afghanistan’

Senator Lindsey Graham (R-South Carolina) on Monday predicted…
Read more